Skip to content

Smoking Cessation Program Among Adolescents in Vocational Training Centers

Evaluation of a Smoking Cessation Program Among ADOlescents in Vocational Training Centers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00973570
Acronym
TABADO
Enrollment
2000
Registered
2009-09-09
Start date
2008-02-29
Completion date
2010-01-31
Last updated
2025-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use

Keywords

tobacco cessation, evaluation, epidémiology, adolescent, apprentices

Brief summary

Background: Most of the efforts to fight against young people's tobacco addiction have focused on smoking prevention and little on smoking cessation. A smoking cessation program, associating pharmacologic and cognitive-behavioural strategy, on a particularly vulnerable population (vocational trainees), was developed by a team of tobacco addiction specialist physicians. We developed a study to evaluate the efficacy of the program. Its main objective is to compare the efficacy of a smoking cessation program offered to all smokers in a population aged 15 to 20 years in Vocational Training Centers (VTC) with that in a control population. The objective of this paper is to present the TABADO study protocol and the results of the pilot study. Methods: The study is quasi-experimental, prospective, evaluative and comparative and takes place during the 2 years of vocational training. The final population will be composed of 2000 trainees entering a VTC (in Lorraine, France): The intervention group (1000 trainees) benefited from the TABADO program while no specific intervention took place in the control group (1000 trainees) other than the treatment and education services usually available. Our primary outcome will be the tobacco abstinence rate at 12 months. The pilot study is a descriptive monocentric cross-sectional study conducted among the whole group of students, completed by a longitudinal prospective study of smoker volunteers.

Interventions

BEHAVIORALTABADO program

The intervention takes place in 3 stages: (i) a general information session on tobacco consumption is delivered to all teenagers, both smokers and nonsmokers. (ii) For smokers wishing to join the program, this session is followed by individualized consultations with a team of tobacco addiction physicians. (iii) The volunteers then benefit from a small group approach, consisting of discussion sessions to share experiences, strengthen motivation, and prevent relapse. There will be 4 sessions in total, comprising individual counseling and work in groups spread over 3 months (taking into account the availability of the trainees because of their alternate-week training schedule).

Sponsors

University of Nancy
CollaboratorOTHER
Central Hospital, Nancy, France
CollaboratorOTHER
Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

* All students, males and females, registered in the VTC for at least a 2-year training period * Aged from 15 to 20 years

Exclusion criteria

* Subjects with current serious psychiatric disorders or who may be susceptible to decompensation upon quitting smoking (major depression) * Smokers who are involved in an ongoing attempt to quit, with medical monitoring.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the rate of smoking abstinence after 12 months, measured on the basis of the statements of the whole sample, not only among volunteers.12 months

Secondary

MeasureTime frame
Overall prevalence of tobacco use in the institutions concerned at 12 months.12 months
Students' motivation to quit smoking (motivational score) and frequency of attempts to quit within the 12 months after the intervention12 months
Rate of withdrawal from the program among the volunteers after 12 months.12 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026